Navigation Links
Quark Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
Date:12/1/2008

Presentation to Highlight Results of Ocular Neuroprotection Candidate

FREMONT, Calif., Dec. 1 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that its Chief Operating Officer, Dr. Rami Skaliter is scheduled to present results on the Company's ocular neuroprotection candidate at the 20th Annual Piper Jaffray Health Care Conference to be held December 2-3, 2008 at the New York Palace in New York City.

                       Event: 20th Annual Piper Jaffray Health Care Conference
                       Date:  Tuesday, December 2, 2008
                       Time:  11:30 am ET

As previously announced, the ocular neuroprotection candidate is the Company's first RNAi drug candidate having a novel, proprietary structure covered by Quark's intellectual property. Data has validated its neuroprotective effects on dying retinal ganglion cells, a cause of blindness and glaucoma.

About Quark Pharmaceuticals, Inc.

Quark Pharmaceuticals, Inc. is a development-stage pharmaceutical company engaged in discovering and developing novel therapeutic RNAi drug candidates. Quark has a fully integrated drug development platform that spans therapeutic target identification to drug development. Quark's RNAi technology includes novel siRNA structures and chemistry providing Quark with freedom to operate in the siRNA intellectual property arena, as well as the ability for non-invasive delivery of siRNA to target tissues including the eye, ear, kidney, lung, spinal cord and brain.

PF-4523655 (RTP801i-14), currently in Phase II clinical trials, is a synthetic, chemically modified, siRNA molecule to inhibit the expression of the gene RTP801 discovered by Quark through the gene discovery platform BiFAR. PF-4523655 is licensed to Pf
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... California (PRWEB) October 20, 2014 Final Cut ... the release of the Citrus theme for FCPX filmmakers ... would use to describe the Citrus theme” Says Christina Austin, ... easy to look so professional.” , Citrus comes with all ... with the template are: four transitions for added style, a ...
(Date:10/20/2014)... October 20, 2014 Houston plastic surgeon ... the key elements of his innovative True Form ... plastic surgery residents and faculty at The University ... he, too, was once a medical student. Patronella, who ... private cosmetic plastic surgery practices in Texas, The ...
(Date:10/19/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of ... bamboo deckings . Moreover, the company has launched a ... available at deeply discounted rates. , As is ... the significance of online business nowadays. Thus, BambooIndustry.com pays ... workers are striving to deliver both value and efficiency ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its newest ... and HostMonster are the best VPS hosting suppliers ... is the method of partitioning a physical server ... the appearance and capabilities of running on someone’s ... pays close attention to VPS products and related ...
(Date:10/19/2014)... Stephen T. Greenberg, M.D., with offices in Woodbury, Southampton and ... as one of Long Island’s best cosmetic surgeons. In ... the best provider for Botox injections. Glisten, his Skin & ... best Laser Treatment center on Long Island.* , The voting ... the contest once per day, per IP address. , Stephen ...
Breaking Medicine News(10 mins):Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2
... Feb. 12 After Phil Cohen, president of ... interview last year, he signed on to do ... introduced those videos this week via PRN Funding,s ... formal launch of its YouTube Channel in place, ...
... Altmeyer brings extensive experience in neuroscience and oncology ... these therapeutic categories , , ROCKVILLE, ... America Pharmaceutical, Inc. (OAPI), a fast-growing health care ... in North America, has announced the appointment of ...
... Earns Milestone Payment of Additional $2.5 MillionCRANBURY, N.J., ... US: PTN) today announced it has received $4.1 ... its exclusive research collaboration and license agreement to ... receptors and a clinical trial sponsored research agreement. ...
... N.J., Feb. 12 DOR BioPharma, Inc. (OTC Bulletin ... it has signed a potential $30 million partnering agreement ... for the development and commercialization in North America of ... the agreement, Sigma - Tau will make a $6 ...
... Will Now Be Available to a Wider Medical Market through Nation,s ... ... 2009 -- Inviro Medical Devices, an industry leader in infection control ... of the nation,s largest and most respected GPOs, or group provider ...
... Montgomery law firm prevails on behalf of plaintiff in medical malpractice lawsuit ... hours of deliberations , ... Santa Rosa, Calif. (Lexis Nexis) February 12, ... the Santa Rosa law firm of Teal & Montgomery, scored a major ...
Cached Medicine News:Health News:PRN Funding Introduces the PRN Funding YouTube Channel 2Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 2Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 3Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 4Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 5Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 6Health News:Palatin Technologies Announces Receipt of $4.1 Million from AstraZeneca 2Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 2Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 3Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 4Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 5Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 6Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 7Health News:Inviro Medical Devices Is Awarded a Three Year Contract with Leading GPO Novation 2Health News:Steve Teal, Santa Rosa Attorney, Obtains $850,000 for Client in Highest Hospital Negligence Verdict in Mendocino County 2
(Date:10/17/2014)... BALTIMORE , Oct. 17, 2014  Ameritox SM ... announced the appointment of Thomas Smith , M.D., ... lead a field-based team offering scientific resources for healthcare ... Smith has held leadership positions at a variety of ... will benefit both the pain and behavioral health sides ...
(Date:10/17/2014)... --  ndd Medical Technologies , a leader in innovative ... announced that its EasyOne Pro® is now being used ... 140,000 square foot, 44-bed hospital with many outpatient services. ... a large number of Native Americans from several tribes ... beyond. A portion of its funding comes from the ...
(Date:10/17/2014)... 2014  STAAR Surgical Company (NASDAQ: STAA ), ... systems for the eye, today announced that the Company will ... October 18, 7:00 a.m. CT at the American Academy of ... Dr. Erik Mertens , Medical Director ... Antwerp, Belgium , will present his first cases with ...
Breaking Medicine Technology:Ameritox Appoints New Chief Medical Officer 2EasyOne Pro Mobile Respiratory Testing from ndd Medical Technologies Chosen by Choctaw Nation 2STAAR Surgical to Webcast Investor Presentations at American Academy of Ophthalmology's Annual Meeting 2STAAR Surgical to Webcast Investor Presentations at American Academy of Ophthalmology's Annual Meeting 3
... Reportlinker.com announces that a new market ... Medical Imaging Markets: ... http://www.reportlinker.com/p0790439/Medical-Imaging-Markets-MRI-Magnetic-Resonance-Imaging-and-Ultrasound-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ... and potential world market for medical MRI ...
... SAN DIEGO, March 7, 2012   OncoSec Medical ... OncoSec Medical System (OMS) ElectroOncology therapies to treat ... Bhatia, Principal Investigator for the company,s Phase II ... a local Seattle news outlet, The Journal ...
Cached Medicine Technology:Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 2Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 3Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 4Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 5Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 6Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 7Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 8Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 9OncoSec's OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper 2OncoSec's OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper 3OncoSec's OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper 4
Sealing tape featuring 3M adhesive technology. Opaque and strong. Prevents photo-degradation....
Sealing tape featuring 3M adhesive technology. Compatible with DMSO. Good optical quality. Minimal autofluorescence....
Empore Sealing Tape Pads are ideal for covering a 96 well plate during storage or transfer to another work station. Not intended for use with auto-injectors....
... 'A' film is a quick and effective means ... plates and tubes. The compliant inner layer is ... smoothly. This minimizes the risk of aerosol formation ... cut for use with fewer than 96 wells, ...
Medicine Products: